IP83-01: Organ-Specific Efficacy of Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis

IP83-01: Organ-Specific Efficacy of Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis

Monday, May 18, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)
147A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!